Cargando…

D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is the main cause of female infertility. It is a multifactorial disorder with varying clinical manifestations including metabolic/endocrine abnormalities, hyperandrogenism, and ovarian cysts, among other conditions. D-Chiro-inositol (DCI) is the main treatment avai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pericuesta, Eva, Laguna-Barraza, Ricardo, Ramos-Ibeas, Priscila, Gutierrez-Arroyo, Julia L., Navarro, Juan A., Vera, Katia, Sanjuan, Carlos, Baixeras, Elena, de Fonseca, Fernando Rodríguez, Gutierrez-Adan, Alfonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504697/ https://www.ncbi.nlm.nih.gov/pubmed/32842637 http://dx.doi.org/10.3390/ijms21176049

Ejemplares similares

Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion
por: Gómez-Redondo, Isabel, et al.
Publicado: (2020)

Intracytoplasmic Sperm Injection Using DNA-Fragmented Sperm in Mice Negatively Affects Embryo-Derived Embryonic Stem Cells, Reduces the Fertility of Male Offspring and Induces Heritable Changes in Epialleles
por: Ramos-Ibeas, Priscila, et al.
Publicado: (2014)

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)

Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
por: Tortolini, Cristina, et al.
Publicado: (2023)

Postnatal Catch-Up Growth Programs Telomere Dynamics and Glucose Intolerance in Low Birth Weight Mice
por: Pericuesta, Eva, et al.
Publicado: (2021)

The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
por: Pintaudi, Basilio, et al.
Publicado: (2016)

CONCERN: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2012)

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
por: Yang, Hyun, et al.
Publicado: (2022)

Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review
por: Bizzarri, Mariano, et al.
Publicado: (2023)

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
por: Troisi, Jacopo, et al.
Publicado: (2019)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

Expression of Concern to: Does ovary need D-chiro-inositol?
por: Isabella, Rosalbino, et al.
Publicado: (2018)

D-Chiro-Inositol Regulates Insulin Signaling in Human Adipocytes
por: Montt-Guevara, Maria Magdalena, et al.
Publicado: (2021)

The effect of D-chiro-inositol on renal protection in diabetic mice
por: Fan, Chunxue, et al.
Publicado: (2022)

D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study
por: Porcaro, Giuseppina, et al.
Publicado: (2023)

Successful ICSI in Mice Using Caput Epididymal Spermatozoa
por: Fernández-González, Raúl, et al.
Publicado: (2019)

New Insights into the Activities of D-Chiro-Inositol: A Narrative Review
por: Gambioli, Riccardo, et al.
Publicado: (2021)

Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside
por: Nordio, Maurizio, et al.
Publicado: (2023)

PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
por: Monastra, Giovanni, et al.
Publicado: (2021)

Antioxidant Nobiletin Enhances Oocyte Maturation and Subsequent Embryo Development and Quality
por: Cajas, Yulia N., et al.
Publicado: (2020)

Potential Health Risks Associated to ICSI: Insights from Animal Models and Strategies for a Safe Procedure
por: Sánchez-Calabuig, María Jesús, et al.
Publicado: (2014)

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review
por: Davinelli, Sergio, et al.
Publicado: (2020)

Determination of Urinary Myo-/Chiro-Inositol Ratios from Korean Diabetes Patients
por: Jung, Tae-Sik, et al.
Publicado: (2005)

D-Chiro-Inositol Improves Sperm Mitochondrial Membrane Potential: In Vitro Evidence
por: Condorelli, Rosita A., et al.
Publicado: (2020)

Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development
por: Gómez-Redondo, Isabel, et al.
Publicado: (2022)

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome
por: Cheang, Kai I., et al.
Publicado: (2016)

Myo-Inositol’s Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome
por: Gupta, Deepti, et al.
Publicado: (2020)

D-Chiro-Inositol – Its Functional Role in Insulin Action and its Deficit in Insulin Resistance
por: Larner, Joseph
Publicado: (2002)

Determination of neo- and d-chiro-Inositol Hexakisphosphate in Soils by Solution (31)P NMR Spectroscopy
por: Turner, Benjamin L., et al.
Publicado: (2012)

Urinary Chiro- and Myo-Inositol Levels as a Biological Marker for Type 2 Diabetes Mellitus
por: Hong, Jun Hwa, et al.
Publicado: (2012)

Myoinositol and D-Chiro Inositol in Improving Insulin Resistance in Obese Male Children: Preliminary Data
por: Mancini, Mario, et al.
Publicado: (2016)

Direct Effects of D-Chiro-Inositol on Insulin Signaling and Glucagon Secretion of Pancreatic Alpha Cells
por: Filippello, Agnese, et al.
Publicado: (2020)

Effects of D-Chiro-Inositol on Glucose Metabolism in db/db Mice and the Associated Underlying Mechanisms
por: Fan, Chunxue, et al.
Publicado: (2020)

Differential Gene Expression and Biological Analyses of Primary Hepatocytes Following D-Chiro-Inositol Supplement
por: Cheng, Feier, et al.
Publicado: (2021)

Loss of the importin Kpna2 causes infertility in male mice by disrupting the translocation of testis-specific transcription factors
por: Navarrete-López, Paula, et al.
Publicado: (2023)

A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
por: Benelli, Elena, et al.
Publicado: (2016)

Senescence and Apoptosis During in vitro Embryo Development in a Bovine Model
por: Ramos-Ibeas, Priscila, et al.
Publicado: (2020)

d-chiro-Inositol Ribophostin: A Highly Potent Agonist of d-myo-Inositol 1,4,5-Trisphosphate Receptors: Synthesis and Biological Activities
por: Mills, Stephen J., et al.
Publicado: (2020)

D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2)
por: Monastra, Giovanni, et al.
Publicado: (2023)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Nordio, Maurizio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afispeevkn6r83ljbac7vlb5tq